GlassScriptPhysician profile
Mayank P Patel
NPI 1609316140
$8,293.74
in general payments reported to CMS, 2019-2025
19 companies · $604 in 2025
The $604 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2022: $35.45 · 2023: $3,120 · 2024: $4,377 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,714 · Food and Beverage: $3,385 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,714.30 |
| Food and Beverage | $3,385.14 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,204.22 | 2023-2024 | Watchman Flx, Rotablator Rotational Atherectomy System Console Kit, Opticross |
| Edwards Lifesciences Corporation | $2,916.31 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $746.97 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $384.35 | 2023-2024 | Impella |
| Bridgebio Pharma, INC. | $184.36 | 2025 | Attruby |
| Abbott Laboratories | $142.27 | 2025 | Dragonfly Opstar |
| Medtronic, INC. | $140.74 | 2024 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.91 | 2019-2023 | Lifevest |
| Insmed, INC. | $83.67 | 2019-2024 | Arikayce |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Merck Sharp & Dohme LLC | $70.89 | 2025 | Keytruda |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Shockwave Medical, INC | $38.43 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $31.91 | 2022 | |
| Philips North America LLC | $26.67 | 2024 | (Ao0) Igt Devices Intracardiac |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.20 | 2019 | |
| Atricure, INC. | $16.97 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.74 | 2025 | |
| Irhythm Technologies, INC. | $14.13 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.